Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Bionik Labaratories

Explore full profile

Innovative medical device and robotics company

Watertown, United StatesFounded 2009Health Tech & Medtech
Revenue $1.8M Latest reported FY

About Bionik Labaratories

Bionik Laboratories, founded in 2010 by Michal Prywata and Thiago Caires, is a publicly traded healthcare company focused on neurorehabilitation technology. The company's strategic direction was significantly shaped by its 2016 acquisition of Interactive Motion Technologies (IMT), a 1998 MIT spin-off founded by pioneers in robotics engineering, Dr. Hermano I. Krebs and Dr. Neville Hogan. This acquisition integrated IMT's established product line and commercial presence into Bionik's portfolio, with Dr. Krebs joining as Chief Science Officer to continue guiding the scientific development rooted in his MIT research.

The company's business model involves direct sales and distribution agreements for its robotic devices to hospitals and rehabilitation clinics worldwide, including partnerships in Asia and across the U.S. with major healthcare providers like Lifepoint Health. Bionik also operates its own neuro-recovery centers, providing direct rehabilitation services to patients, which serves as both a revenue stream and a framework for showcasing its technology's effectiveness. This dual approach allows the company to gather extensive, anonymized patient data through its InMotion Connect platform, a cloud-based analytics tool that helps clinicians monitor progress and refine therapy protocols.

Bionik's core offerings are the InMotion robotic systems, designed for upper-extremity therapy for patients recovering from strokes, spinal cord injuries, and other neurological conditions. The product suite, including the InMotion ARM, HAND, and WRIST, utilizes an "assist-as-needed" therapeutic approach, where the robots provide intelligent, adaptive assistance to help patients complete tasks, aiming to remap neural pathways and restore motor control. These devices also function as diagnostic tools, providing objective data on a patient's impairment and recovery progress. Concurrently, Bionik is developing its ARKE lower-body exoskeleton technology, initially for clinical rehabilitation with a long-term vision to create more accessible, consumer-focused versions for in-home use.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2009
Headquarters
Watertown, United States
Listing
IPO 2019
Sector
Health Tech & Medtech

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • DMZ
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Bionik Labaratories on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bionik Labaratories on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.